Ethylene Market is Expected to Develop at a Modest 6% CAGR through 2031 | SkyQuest Technology

Westford, USA, Oct. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Ethylene market will attain a value of USD 194.7 billion by 2031, with a CAGR of 6% over the forecast period (2024-2031). Rapidly surging demand for packaged products and growing advancements in packaging technology are projected to augment the demand for ethylene in […]

Canadian Investment Regulatory Organization Trading Halt – DCMC

The following issues have been halted by CIRO: Company: Dore Copper Mining Corp. TSX Symbol: DCMC All Issues: Yes Reason: Pending News Halt Time (ET): 7:44 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test

Patent covers proprietary method using methylation of the CCNA1 gene to help detect esophageal precancer and cancer Lucid Diagnostics Inc.(Nasdaq: LUCD)(“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has received a Notice of Allowance from the United States Patent and Trademark

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT(TM) combination with immune check point inhibitor in metastatic breast cancer (MBC) Primary endpoint is overall survival (OS) with Bria-IMT(TM) regimen plus Check Point Inhibitor (CPI) vs treatment of physician’s choice Interim data analysis planned at 144 events (deaths) could provide full approval and

ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome Inhibitors

WESTON, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, was interviewed on the Big Biz Show to address current trends in

Landstar to Release Third Quarter Results on Tuesday, October 29, 2024

JACKSONVILLE, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ:LSTR), announced today it will release its 2024 third quarter results after the market closes on Tuesday, October 29, 2024, and will then hold its quarterly conference call with analysts and investors at 4:30 p.m. ET that evening to discuss the third quarter results

DermCare Management Expands California Footprint with Partnership at Contour Dermatology & Cosmetic Surgery Center

DermCare Management, a premier provider of dermatology and cosmetic surgery practice management services in Florida, Texas, California, and Virginia, is excited to announce the expansion of its family with a new partnership in California, increasing its total number of locations to 81. https://mma.prnewswire.com/media/1736237/DermCare_Logo.jpg “We are excited to add Dr. Jochen and the entire team at

Heartland Dental Featured on Emmy-Nominated Series, Tomorrow’s World Today

The episode is scheduled to premiere October 20th on the Discovery Channel Heartland Dental, the nation’s leading dental support organization, is excited to announce that the company will be featured on the seventh season of the Emmy-nominated series, Tomorrow’s World Today. The episode, scheduled to premiere on October 20th on the Discovery Channel, will delve

Trailbreaker Initiates Multiple Geophysical Surveys at the Liberty Copper-Molybdenum Project, British Columbia

VANCOUVER, British Columbia, Oct. 15, 2024 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) is pleased to announce the mobilization of geophysical crews from Geotech Ltd. and Simcoe Geoscience Ltd. (“Simcoe”) to conduct Z-axis Tipper Electromagnetic (ZTEM) and induced polarization (IP) surveys, respectively, at the Liberty copper (Cu) – molybdenum (Mo) project,

Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference

Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee’s Oral Delivery of Biologics Platform at the 14th Annual PODD Conference – Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024. https://mma.prnewswire.com/media/2530888/PODD_2024.jpg Presentation Title: “Breakthrough Device for Oral Delivery of Biologics”.Date & Time: October 22, 2024,

Scroll to Top